Exploring Haptoglobin as a Promising Marker for Severe Liver Diseases: A Comprehensive Review
DOI:
https://doi.org/10.12775/QS.2024.31.55911Keywords
haptoglobin, liver damage, haptoglobin level in liver injury, diagnosis of liver damage, diseases associated with liver damage, acute phase reaction, liver damage biomarkers, haptoglobin measurement methodsAbstract
Liver damage is a common symptom of many diseases, including metabolic disorders and cancers. Such patient condition requires effective examinations aimed at prompt diagnosis and implementation of the most appropriate treatment for a specific disease. Haptoglobin, the subject of many studies, has proven to be a protein that can be used as a biomarker of liver damage, thereby aiding not only in the diagnosis but also in the treatment, resulting in more favorable prognoses regarding patient longevity and quality of life.
The aim of this study is to elucidate the role of haptoglobin as a diagnostic and prognostic biomarker in cases of liver damage.
This is a review of scientific literature and analysis of clinical data regarding haptoglobin levels in liver damage were conducted to assess the reliability of haptoglobin as a biomarker.This paper primarily utilized the latest publications produced after 2015. PubMed and Google Scholar were used to find relevant publications. All cited works provided useful information to achieve the aim of our article.
Analysis of the literature suggests that haptoglobin levels may be significantly associated with the development and severity of liver damage. It may serve as a suitable biomarker for diagnosing diseases that coincide with hepatocyte damage, thus improving the diagnosis of these diseases and increasing the chance of appropriate treatment, which may contribute to prolonging and improving the patient's quality of life.
Haptoglobin appears to be a promising biomarker in liver damage; however, further research is necessary to confirm its diagnostic and prognostic accuracy. Haptoglobin exists in various genotypic forms, each characteristic of different disease entities. Understanding the mechanisms regulating haptoglobin levels may lead to a better understanding of liver damage pathogenesis and the development of more effective therapies, increasing the chance of patient recovery and improving their quality of life.
References
References:
Andersen CBF, Stødkilde K, Sæderup KL, et al. Haptoglobin. Antioxid Redox Signal.
May 10;26(14):814-831. doi: 10.1089/ars.2016.6793.
Podlak Dawidziak M, Solnica B, Hemoglobina i Hemopeksyna w Gajewski P. (red.), Interna Szczeklika. Kraków Medycyna Praktyczna 2023, s. 1777-1778.
Edwards O, Burris A, Lua J, et al. Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients. Genes (Basel). 2022;13(1):144. Published 2022 Jan
doi:10.3390/genes13010144
Hostettler IC, Morton MJ, Ambler G, et al. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry.
;91(3):298-304. doi:10.1136/jnnp-2019-321774
Kalmovarin N, Friedrichs WE, O'Brien HV, et al. Extrahepatic expression of plasma protein genes during inflammation. Inflammation. 1991;15(5):369-379. doi:10.1007/BF00917353
Yang F, Friedrichs WE, Navarijo-Ashbaugh AL, et al. Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab Invest. 1995 Sep;73(3):433-40. PMID: 7564277.
Barcellini W, Fattizzo B. Clinical Applications of Hemolytic Markers in the
Differential Diagnosis and Management of Hemolytic Anemia. Dis Markers.
;2015:635670. doi:10.1155/2015/635670
Raju SM, Kumar AP, Yadav AN, et al. Haptoglobin improves acute phase response and endotoxin tolerance in response to bacterial LPS. Immunol Lett. 2019;207:17-27. doi:10.1016/j.imlet.2019.01.002
Shih AW, McFarlane A, Verhovsek M. Haptoglobin testing in hemolysis: measurement and interpretation. Am J Hematol. 2014;89(4):443-447. doi:10.1002/ajh.23623
Katarzyna N., Podstawy diagnostyki immunologicznej, Bryniarski K., Siedlar M
Immunologia. 2nd ed. Wrocław (Poland) Urban & Partner. 2023. s. 305
Brady N, O'Reilly EL, McComb C, et al. An immunoturbidimetric assay for bovine haptoglobin. Comp Clin Path. 2019;28(1):21-27. doi:10.1007/s00580-018-2863-6
Thuillier F, Demarquilly C, Szymanowicz A, et al. Turbidimétrie ou néphélémétrie: quel choix pour les dosages de l'albumine, l'ApoA, la CRP, l'haptoglobine, l'IgM et la transthyrétine? [Nephelometry or turbidimetry for the determination of albumin,
ApoA, CRP, haptoglobin, IgM and transthyretin: which choice?]. Ann Biol Clin
(Paris). 2008;66(1):63-78. doi:10.1684/abc.2008.0192
Munoz CJ, Pires IS, Baek JH, et al. Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme. Am J Physiol Heart
Circ Physiol. 2020;318(5):H1296-H1307. doi:10.1152/ajpheart.00136.2020
Więcek M., Metabolizm Wysiłkowy w Cięszczyk P (red.), Biochemia Sportowa.
Warszawa: PZWL, 2023, s.230
Hasan A, Maciejewski D, Chmielniak S, et al. Medipage. Praktyczny podręcznik interpretacji równowagi kwasowo-zasadowej. Warszawa: Medipage, Cop; 2015.
Maciejewska-Skrendo A, Humińska-Lisowska K, Sawczu M, Techniki badań molekularnych stooswane w genetyce sportowej w Cięszczyk P., Genetyka Sportowa.
Warszawa, PZWL, 2021, s. 38-40
Wan BN, Zhou SG, Wang M, et al. Progress on haptoglobin and metabolic diseases.
World J Diabetes. 2021;12(3):206-214. doi:10.4239/wjd.v12.i3.206
Yousif AS, Elagib AA. Haptoglobin Phenotypes and Susceptibility to Schistosoma Parasites Infection in Central Sudan. Mediterr J Hematol Infect Dis.
;9(1):e2017042. Published 2017 Jul 1. doi:10.4084/MJHID.2017.042
Zhou J, Liu J, Sheng H, et al. Haptoglobin 2-2 Genotype is Associated with More
Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective
Study. Adv Ther. 2019;36(4):880-895. doi:10.1007/s12325-019-00902-z
You N, Lu Y, Yan X, et al. Haptoglobin 2-2 Genotype is Related to the Severity of Liver Damage in Hepatitis B Patients with Liver Steatosis. Discov Med.
;35(179):982-987. doi:10.24976/Discov.Med.202335179.94
Kamada Y, Akita M, Takeda Y, et al. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. PLoS One. 2013;8(6):e66328. Published 2013 Jun 21. doi:10.1371/journal.pone.0066328
Sun L, Hu S, Yu L, et al. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis. Int J Cancer.
;138(11):2724-2731. doi:10.1002/ijc.29993
Peta V, Zhu J, Lubman DM, et al. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
Clin Res Hepatol Gastroenterol. 2020;44(5):681-691.
doi:10.1016/j.clinre.2019.12.010
Naryzny SN, Legina OK. Haptoglobin as a Biomarker. Biochem Mosc Suppl B
Biomed Chem. 2021;15(3):184-198. doi:10.1134/S1990750821030069
Pompach P, Brnakova Z, Sanda M, et al. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics.
;12(5):1281-1293. doi:10.1074/mcp.M112.023259
Tawara S, Tatsumi T, Iio S, et al. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C. PLoS One. 2016;11(3):e0151828. Published 2016 Mar 22. doi:10.1371/journal.pone.0151828
Gunzer S, Kraus A, Buchroth I, et al. Hypertransaminasemia and liver fibrosis associated with haptoglobin retention and anhaptoglobinemia in a paediatric patient. Liver Int. 2021 Oct;41(10):2427-2432. doi: 10.1111/liv.15029.
Naryzny SN, Legina OK. Haptoglobin as a Biomarker. Biochem Mosc Suppl B Biomed Chem. 2021;15(3):184-198. doi: 10.1134/S1990750821030069.
Lin Y, Zhu J, Zhang J, et al. Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis
Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method. ACS Omega. 2022 Jun 22;7(26):22850-22860. doi: 10.1021/acsomega.2c02600.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Daria Ziemińska, Rafał Burczyk, Wiktor Wardyn, Martyna Michalska, Karolina Winiarek, Joanna Murawska, Cezary Guzowski, Kornelia Kędziora-Kornatowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 80
Number of citations: 0
